Alternatives to EMRIS Pharma

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Biotechnology company developing novel therapies for multiple myeloma.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.